Moderna Posts Wider-Than-Expected Q4 Loss, 2025 Sales Guide Disappoints
Moderna reported a wider loss than expected for the fourth quarter on Friday morning, and the drugmaker's sales forecast for ...
Kinsale's Q4 Profits Hurt by Hurricanes
Beyond the headlines, Kinsale's operating earnings increased by 19% on a per-share basis, and the company's gross written premiums (a good measure of the growth of its insurance business) increased by ...
Applied DNA Reports First Quarter Fiscal 2025 Financial Results and Highlights Operational Progress
In December 2024, the Company announced a strategic restructuring of its business operations, including the potential divestiture of its DNA Tagging and Security Products and Services ("DNA Tagging") ...
CVS Beats EPS Estimates, Losses Loom
The earnings surpassed analyst expectations with an adjusted earnings per share (EPS) of $1.19, beating estimates of $0.91 by ...